Aldehyde dehydrogenase, mitochondrial
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 4 PDB declaration: tetrameric(4) Consistent with protein copy count | Chain A; UniProt 18–517 Chain B; UniProt 18–517 Chain C; UniProt 18–517 Chain D; UniProt 18–517 | Fragment:Mature sequence, residues 18-517 Mutation:T244A | NA SODIUM ION × 4 GAI GUANIDINE × 7 EDO 1,2-ETHANEDIOL × 11 ADP ADENOSINE-5'-DIPHOSPHATE × 4 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K | Resolution 1.90 Å R-free 0.232 |
| 2 | Protein homooligomer Homooligomer Protein × 4 PDB declaration: tetrameric(4) Consistent with protein copy count | Chain E; UniProt 18–517 Chain F; UniProt 18–517 Chain G; UniProt 18–517 Chain H; UniProt 18–517 | Fragment:Mature sequence, residues 18-517 Mutation:T244A | NA SODIUM ION × 4 GAI GUANIDINE × 9 EDO 1,2-ETHANEDIOL × 12 ADP ADENOSINE-5'-DIPHOSPHATE × 4 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K | Resolution 1.90 Å R-free 0.232 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3N83 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1CW3 HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ AND MN2+ Deposited 1999-08-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain B
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain C
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain D
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
|
Not recorded | MN MANGANESE (II) ION × 4 MG MAGNESIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;100 MM ACES, PH 6.4, 100 MM GUANIDINE-HCL, 2 MM NAD+, 4 MM DTT, 16% PEG 6000,
8 MG/ML ENZYME SOAKED WITH 8 MM MNCL2 FOR 2 DAYS, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.58 Å R-free 0.242 |
| 1CW3 HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ AND MN2+ Deposited 1999-08-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain F
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain G
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
Chain H
24–517(494 aa)
Fragment:COMPLETE MATURE SEQUENCE (DOES NOT INCLUDE MITOCHONDRIAL LEADER SEQUENCE)
|
Not recorded | MN MANGANESE (II) ION × 4 MG MAGNESIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;100 MM ACES, PH 6.4, 100 MM GUANIDINE-HCL, 2 MM NAD+, 4 MM DTT, 16% PEG 6000,
8 MG/ML ENZYME SOAKED WITH 8 MM MNCL2 FOR 2 DAYS, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.58 Å R-free 0.242 |
| 1NZW Cys302Ser mutant of human mitochondrial aldehyde dehydrogenase complexed with NADH and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Mutation:C302S Mutation:C302S Mutation:C302S Mutation:C302S | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NADH at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.65 Å R-free 0.252 |
| 1NZW Cys302Ser mutant of human mitochondrial aldehyde dehydrogenase complexed with NADH and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Mutation:C302S Mutation:C302S Mutation:C302S Mutation:C302S | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NADH at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.65 Å R-free 0.252 |
| 1NZX Human mitochondrial aldehyde dehydrogenase complexed with NAD+ in the presence of low Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked at decreasing concentrations of Mg2+ and then with NAD+ and 0 Mg2+ prior to data collection. , pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.45 Å R-free 0.245 |
| 1NZX Human mitochondrial aldehyde dehydrogenase complexed with NAD+ in the presence of low Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked at decreasing concentrations of Mg2+ and then with NAD+ and 0 Mg2+ prior to data collection. , pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.45 Å R-free 0.245 |
| 1NZZ Human mitochondrial aldehyde dehydrogenase complexed with NADH in the presence of low Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked at increasing pH and decreasing concentrations of Mg2+ and then with NADH and 0.2 mM Mg2+ at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.45 Å R-free 0.248 |
| 1NZZ Human mitochondrial aldehyde dehydrogenase complexed with NADH in the presence of low Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked at increasing pH and decreasing concentrations of Mg2+ and then with NADH and 0.2 mM Mg2+ at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.45 Å R-free 0.248 |
| 1O00 Human mitochondrial aldehyde dehydrogenase complexed with NAD+ and Mg2+ showing dual NAD(H) conformations Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NAD+ at pH 6.4 prior to data collection., VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å R-free 0.232 |
| 1O00 Human mitochondrial aldehyde dehydrogenase complexed with NAD+ and Mg2+ showing dual NAD(H) conformations Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NAD+ at pH 6.4 prior to data collection., VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å R-free 0.232 |
| 1O01 Human mitochondrial aldehyde dehydrogenase complexed with crotonaldehyde, NAD(H) and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 CRD (2E)-BUT-2-ENAL × 3 EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT, NAD+. Crystal soaked with crotonaldehyde prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.15 Å R-free 0.206 |
| 1O01 Human mitochondrial aldehyde dehydrogenase complexed with crotonaldehyde, NAD(H) and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 CRD (2E)-BUT-2-ENAL × 3 EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT, NAD+. Crystal soaked with crotonaldehyde prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.15 Å R-free 0.206 |
| 1O02 Human mitochondrial aldehyde dehydrogenase complexed with NADH in the presence of Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 8 EDO 1,2-ETHANEDIOL × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NADH at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.90 Å R-free 0.213 |
| 1O02 Human mitochondrial aldehyde dehydrogenase complexed with NADH in the presence of Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 8 EDO 1,2-ETHANEDIOL × 4 NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT. Crystal soaked with NADH at pH 7.0 prior to data collection., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.90 Å R-free 0.213 |
| 1O04 Cys302Ser mutant of human mitochondrial aldehyde dehydrogenase complexed with NAD+ and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Mutation:C302S Mutation:C302S Mutation:C302S Mutation:C302S | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 GAI GUANIDINE × 9 EDO 1,2-ETHANEDIOL × 16 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.42 Å R-free 0.171 |
| 1O04 Cys302Ser mutant of human mitochondrial aldehyde dehydrogenase complexed with NAD+ and Mg2+ Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Mutation:C302S Mutation:C302S Mutation:C302S Mutation:C302S | NA SODIUM ION × 4 MG MAGNESIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 GAI GUANIDINE × 9 EDO 1,2-ETHANEDIOL × 16 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.42 Å R-free 0.171 |
| 1O05 Apo form of human mitochondrial aldehyde dehydrogenase Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain B
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain C
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain D
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.25 Å R-free 0.216 |
| 1O05 Apo form of human mitochondrial aldehyde dehydrogenase Deposited 2003-02-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain F
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain G
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
Chain H
18–517(500 aa)
Fragment:Complete mature sequence (does not contain mitochondrial leader sequence).
|
Not recorded | NA SODIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;ACES, PEG 6000, Guanidine HCl, MgCl2, DTT., pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.25 Å R-free 0.216 |
| 1ZUM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, Apo Form Deposited 2005-05-31 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 4 GAI GUANIDINE × 1 EDO 1,2-ETHANEDIOL × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), magnesium chloride, Guanidine HCl, PEG 6000, DTT, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.238 |
| 1ZUM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, Apo Form Deposited 2005-05-31 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 4 GAI GUANIDINE × 5 EDO 1,2-ETHANEDIOL × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), magnesium chloride, Guanidine HCl, PEG 6000, DTT, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.238 |
| 1ZUM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, Apo Form Deposited 2005-05-31 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain I
18–517(500 aa)
Chain J
18–517(500 aa)
Chain K
18–517(500 aa)
Chain L
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 4 GAI GUANIDINE × 2 EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), magnesium chloride, Guanidine HCl, PEG 6000, DTT, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.238 |
| 2ONM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with NAD+ Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 6 ADP ADENOSINE-5'-DIPHOSPHATE × 2 EDO 1,2-ETHANEDIOL × 8 GAI GUANIDINE × 2 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 15% w/v PEG 6000, 8mM DTT, pH 6.8, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.50 Å R-free 0.271 |
| 2ONM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with NAD+ Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 6 ADP ADENOSINE-5'-DIPHOSPHATE × 1 EDO 1,2-ETHANEDIOL × 12 GAI GUANIDINE × 5 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 15% w/v PEG 6000, 8mM DTT, pH 6.8, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.50 Å R-free 0.271 |
| 2ONM Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with NAD+ Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain I
18–517(500 aa)
Chain J
18–517(500 aa)
Chain K
18–517(500 aa)
Chain L
18–517(500 aa)
|
Mutation:E487K Mutation:E487K Mutation:E487K Mutation:E487K | NA SODIUM ION × 5 ADP ADENOSINE-5'-DIPHOSPHATE × 4 EDO 1,2-ETHANEDIOL × 5 GAI GUANIDINE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 15% w/v PEG 6000, 8mM DTT, pH 6.8, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.50 Å R-free 0.271 |
| 2ONN Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, Apo form Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 4 mM DTT, pH 6.6, vapor diffusion, temperature 293K
|
Resolution 2.75 Å R-free 0.268 |
| 2ONN Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, Apo form Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 4 mM DTT, pH 6.6, vapor diffusion, temperature 293K
|
Resolution 2.75 Å R-free 0.268 |
| 2ONO Arg475Gln Mutant of Mitochondrial Aldehyde Dehydrogenase, apo form, pseudo-merohedrally twinned Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 5 mM MgCl2, 100 mM Guanidine HCl, 18% w/v PEG 6000, 6 mM DTT, pH 6.6, vapor diffusion, temperature 293K, pH 6.60
|
Resolution 2.15 Å R-free 0.314 |
| 2ONO Arg475Gln Mutant of Mitochondrial Aldehyde Dehydrogenase, apo form, pseudo-merohedrally twinned Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 5 mM MgCl2, 100 mM Guanidine HCl, 18% w/v PEG 6000, 6 mM DTT, pH 6.6, vapor diffusion, temperature 293K, pH 6.60
|
Resolution 2.15 Å R-free 0.314 |
| 2ONP Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, complexed with NAD+ Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 EDO 1,2-ETHANEDIOL × 19 GAI GUANIDINE × 15 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 8 mM DTT, pH 6.6, vapor diffusion, temperature 293K
|
Resolution 2.00 Å R-free 0.240 |
| 2ONP Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, complexed with NAD+ Deposited 2007-01-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:R475Q Mutation:R475Q Mutation:R475Q Mutation:R475Q | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 EDO 1,2-ETHANEDIOL × 20 GAI GUANIDINE × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.6;293 K;100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 8 mM DTT, pH 6.6, vapor diffusion, temperature 293K
|
Resolution 2.00 Å R-free 0.240 |
| 2VLE The structure of daidzin, a naturally occurring anti alcohol- addiction agent, in complex with human mitochondrial aldehyde dehydrogenase Deposited 2008-01-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain B
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain C
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain D
24–517(494 aa)
Fragment:RESIDUES 24-517
|
Not recorded | DZN DAIDZIN × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;100 MM MES PH 6.5, 100 MM GUANIDINE-HCL, 3 MM DITHIOTHREITOL, 5% DMSO (V/V), 10% PEG 6000 (W/V) AND 2MM DAIDZIN
|
Resolution 2.40 Å R-free 0.249 |
| 2VLE The structure of daidzin, a naturally occurring anti alcohol- addiction agent, in complex with human mitochondrial aldehyde dehydrogenase Deposited 2008-01-13 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain F
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain G
24–517(494 aa)
Fragment:RESIDUES 24-517
Chain H
24–517(494 aa)
Fragment:RESIDUES 24-517
|
Not recorded | DZN DAIDZIN × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;100 MM MES PH 6.5, 100 MM GUANIDINE-HCL, 3 MM DITHIOTHREITOL, 5% DMSO (V/V), 10% PEG 6000 (W/V) AND 2MM DAIDZIN
|
Resolution 2.40 Å R-free 0.249 |
| 3INJ Human Mitochondrial Aldehyde Dehydrogenase complexed with agonist Alda-1 Deposited 2009-08-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Not recorded | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 9 GAI GUANIDINE × 4 BXB N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 8MM DTT, pH 6.4, VAPOR DIFFUSION, temperature 292K
|
Resolution 1.69 Å R-free 0.200 |
| 3INJ Human Mitochondrial Aldehyde Dehydrogenase complexed with agonist Alda-1 Deposited 2009-08-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Not recorded | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 7 GAI GUANIDINE × 5 BXB N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 8MM DTT, pH 6.4, VAPOR DIFFUSION, temperature 292K
|
Resolution 1.69 Å R-free 0.200 |
| 3INL Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with agonist Alda-1 Deposited 2009-08-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:E487K, C302S Mutation:E487K, C302S Mutation:E487K, C302S Mutation:E487K, C302S | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 15 BXB N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 8MM DTT, pH 6.4, VAPOR DIFFUSION, temperature 292K
|
Resolution 1.86 Å R-free 0.168 |
| 3INL Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with agonist Alda-1 Deposited 2009-08-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:E487K, C302S Mutation:E487K, C302S Mutation:E487K, C302S Mutation:E487K, C302S | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 16 BXB N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 8MM DTT, pH 6.4, VAPOR DIFFUSION, temperature 292K
|
Resolution 1.86 Å R-free 0.168 |
| 3N80 Human mitochondrial aldehyde dehydrogenase, apo form Deposited 2010-05-27 | Different mutation/modification Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain B
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain C
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain D
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | GAI GUANIDINE × 10 EDO 1,2-ETHANEDIOL × 18 NA SODIUM ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 1.50 Å R-free 0.175 |
| 3N80 Human mitochondrial aldehyde dehydrogenase, apo form Deposited 2010-05-27 | Different mutation/modification Different ligand/ion Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain F
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain G
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain H
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | GAI GUANIDINE × 11 EDO 1,2-ETHANEDIOL × 18 NA SODIUM ION × 4 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 1.50 Å R-free 0.175 |
| 3N81 T244A mutant of Human mitochondrial aldehyde dehydrogenase, apo form Deposited 2010-05-27 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain B
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain C
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain D
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Mutation:T244A Mutation:T244A Mutation:T244A Mutation:T244A | NA SODIUM ION × 4 GAI GUANIDINE × 10 EDO 1,2-ETHANEDIOL × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 1.70 Å R-free 0.217 |
| 3N81 T244A mutant of Human mitochondrial aldehyde dehydrogenase, apo form Deposited 2010-05-27 | Different ligand/ion Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain F
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain G
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain H
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Mutation:T244A Mutation:T244A Mutation:T244A Mutation:T244A | NA SODIUM ION × 4 GAI GUANIDINE × 11 EDO 1,2-ETHANEDIOL × 14 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 1.70 Å R-free 0.217 |
| 3N82 T244A mutant of Human mitochondrial aldehyde dehydrogenase, NADH complex Deposited 2010-05-27 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain B
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain C
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain D
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Mutation:T244A Mutation:T244A Mutation:T244A Mutation:T244A | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 6 EDO 1,2-ETHANEDIOL × 11 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.25 Å R-free 0.219 |
| 3N82 T244A mutant of Human mitochondrial aldehyde dehydrogenase, NADH complex Deposited 2010-05-27 | Different ligand/ion Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain F
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain G
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
Chain H
18–517(500 aa)
Fragment:Mature sequence, residues 18-517
|
Mutation:T244A Mutation:T244A Mutation:T244A Mutation:T244A | MG MAGNESIUM ION × 4 NA SODIUM ION × 4 GAI GUANIDINE × 7 EDO 1,2-ETHANEDIOL × 13 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 1-10MM MGCL2, 100-200 MM GUANIDINE HCL, 16-17% W/V PEG 6000, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.25 Å R-free 0.219 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain B
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 2 GAI GUANIDINE × 4 EDO 1,2-ETHANEDIOL × 3 I3E 1-(4-ethylphenyl)propan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain D
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 2 GAI GUANIDINE × 5 EDO 1,2-ETHANEDIOL × 6 I3E 1-(4-ethylphenyl)propan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain E
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain F
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 2 GAI GUANIDINE × 5 EDO 1,2-ETHANEDIOL × 8 I3E 1-(4-ethylphenyl)propan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain G
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain H
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 2 GAI GUANIDINE × 4 EDO 1,2-ETHANEDIOL × 4 I3E 1-(4-ethylphenyl)propan-1-one × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain B
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain C
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain D
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 4 GAI GUANIDINE × 9 EDO 1,2-ETHANEDIOL × 9 I3E 1-(4-ethylphenyl)propan-1-one × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 3SZ9 Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one Deposited 2011-07-18 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain F
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain G
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
Chain H
18–517(500 aa)
Fragment:Mature sequence, UNP residues 18-517
|
Not recorded | NA SODIUM ION × 4 GAI GUANIDINE × 9 EDO 1,2-ETHANEDIOL × 12 I3E 1-(4-ethylphenyl)propan-1-one × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.4;292 K;100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K
|
Resolution 2.10 Å R-free 0.226 |
| 4FQF Crystal structure of a thionitrate intermediate of human aldehyde dehydrogenase-2 Deposited 2012-06-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Fragment:unp residues 18-517
Chain B
18–517(500 aa)
Fragment:unp residues 18-517
Chain C
18–517(500 aa)
Fragment:unp residues 18-517
Chain D
18–517(500 aa)
Fragment:unp residues 18-517
|
Not recorded | 2NO NITROGEN DIOXIDE × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 MG MAGNESIUM ION × 4 URE UREA × 6 NA SODIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;100 mM bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-TRIS), 25% PEG 3350, 60 mM urea;
13.3 mM magnesium chloride, 8.9 mM tris(2-carboxyethyl)phosphine (TCEP), 4.4 mM NAD+, 45.8 mM glucose, crystals have been soaked with glyceryl trinitrate (GTN), pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.28 Å R-free 0.209 |
| 4FR8 Crystal structure of human aldehyde dehydrogenase-2 in complex with nitroglycerin Deposited 2012-06-26 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
Chain C
18–517(500 aa)
Chain D
18–517(500 aa)
|
Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S | TNG propane-1,2,3-triyl trinitrate × 1 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 3 MG MAGNESIUM ION × 4 URE UREA × 5 NA SODIUM ION × 4 ADP ADENOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;100 mM bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-TRIS), 25% PEG 3350, 60 mM urea; 6.9 mM magnesium chloride, 4.6 mM tris(2-carboxyethyl)phosphine (TCEP), 2.3 mM NAD+, 47.6 mM glucose, crystals have been soaked with glyceryl trinitrate (GTN), pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.20 Å R-free 0.167 |
| 4FR8 Crystal structure of human aldehyde dehydrogenase-2 in complex with nitroglycerin Deposited 2012-06-26 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
18–517(500 aa)
Chain F
18–517(500 aa)
Chain G
18–517(500 aa)
Chain H
18–517(500 aa)
|
Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S Mutation:E268Q, C301S, C303S | NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 1 MG MAGNESIUM ION × 4 URE UREA × 1 NA SODIUM ION × 4 ADP ADENOSINE-5'-DIPHOSPHATE × 3 BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;293 K;100 mM bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (Bis-TRIS), 25% PEG 3350, 60 mM urea; 6.9 mM magnesium chloride, 4.6 mM tris(2-carboxyethyl)phosphine (TCEP), 2.3 mM NAD+, 47.6 mM glucose, crystals have been soaked with glyceryl trinitrate (GTN), pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.20 Å R-free 0.167 |
| 4KWF Crystal Structure Analysis of ALDH2+ALDiB33 Deposited 2013-05-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–517(494 aa)
Fragment:UNP residues 24-517
Chain B
24–517(494 aa)
Fragment:UNP residues 24-517
Chain C
24–517(494 aa)
Fragment:UNP residues 24-517
Chain D
24–517(494 aa)
Fragment:UNP residues 24-517
|
Not recorded | 3AK 1-benzyl-1H-indole-2,3-dione × 2 NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 4 GAI GUANIDINE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
sitting drop;pH 6.4;300 K;100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K
|
Resolution 2.31 Å R-free 0.296 |
| 4KWF Crystal Structure Analysis of ALDH2+ALDiB33 Deposited 2013-05-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
24–517(494 aa)
Fragment:UNP residues 24-517
Chain F
24–517(494 aa)
Fragment:UNP residues 24-517
Chain G
24–517(494 aa)
Fragment:UNP residues 24-517
Chain H
24–517(494 aa)
Fragment:UNP residues 24-517
|
Not recorded | 3AK 1-benzyl-1H-indole-2,3-dione × 2 NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 4 GAI GUANIDINE × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
sitting drop;pH 6.4;300 K;100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K
|
Resolution 2.31 Å R-free 0.296 |
| 4KWG Crystal Structure Analysis of ALDH2+ALDiB13 Deposited 2013-05-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–517(494 aa)
Fragment:UNP residues 24-517
Chain B
24–517(494 aa)
Fragment:UNP residues 24-517
Chain C
24–517(494 aa)
Fragment:UNP residues 24-517
Chain D
24–517(494 aa)
Fragment:UNP residues 24-517
|
Not recorded | 2AK 7-bromo-5-methyl-1H-indole-2,3-dione × 1 NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 4 GAI GUANIDINE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
sitting drop;pH 6.4;300 K;100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K
|
Resolution 2.10 Å R-free 0.229 |
| 4KWG Crystal Structure Analysis of ALDH2+ALDiB13 Deposited 2013-05-24 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
24–517(494 aa)
Fragment:UNP residues 24-517
Chain F
24–517(494 aa)
Fragment:UNP residues 24-517
Chain G
24–517(494 aa)
Fragment:UNP residues 24-517
Chain H
24–517(494 aa)
Fragment:UNP residues 24-517
|
Not recorded | 2AK 7-bromo-5-methyl-1H-indole-2,3-dione × 1 NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 4 GAI GUANIDINE × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
sitting drop;pH 6.4;300 K;100 mM ACES, 100 mm guanidine-HCl, 10 mm MgCl2, and 14-19% PEG 6000, pH 6.4, sitting drop, temperature 300K
|
Resolution 2.10 Å R-free 0.229 |
| 5L13 Structure of ALDH2 in complex with 2P3 Deposited 2016-07-28 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–517(517 aa)
Chain B
1–517(517 aa)
Chain C
1–517(517 aa)
Chain D
1–517(517 aa)
|
Not recorded | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 5 GAI GUANIDINE × 8 6ZE 2,3,5-trimethyl-6-propyl-7H-furo[3,2-g][1]benzopyran-7-one × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;300 K;100 mM ACES, 100 mM guanidine-HCl, 10 mM MgCl2, 4 mM dithiothreitol, 18% PEG6000
|
Resolution 2.40 Å R-free 0.206 |
| 5L13 Structure of ALDH2 in complex with 2P3 Deposited 2016-07-28 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain E
1–517(517 aa)
Chain F
1–517(517 aa)
Chain G
1–517(517 aa)
Chain H
1–517(517 aa)
|
Not recorded | NA SODIUM ION × 4 EDO 1,2-ETHANEDIOL × 7 GAI GUANIDINE × 8 6ZE 2,3,5-trimethyl-6-propyl-7H-furo[3,2-g][1]benzopyran-7-one × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.4;300 K;100 mM ACES, 100 mM guanidine-HCl, 10 mM MgCl2, 4 mM dithiothreitol, 18% PEG6000
|
Resolution 2.40 Å R-free 0.206 |
| 8DR9 Crystal structure of human ALDH2 in complex with NAD+ and PEG MME 550 Deposited 2022-07-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
18–517(500 aa)
Chain B
18–517(500 aa)
|
Mutation:C302S Mutation:C302S | CIT CITRIC ACID × 4 NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 4 NA SODIUM ION × 4 1PE PENTAETHYLENE GLYCOL × 18 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.2;293 K;protein conditions: 8 mg/ml recombinant ALDH2 in 20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM DTT, supplemented with 2-4% v/v DMSO
well conditions: 100 mM sodium citrate, pH 5.0-5.6, 22-26% w/v PEG MME 550 550
hanging drops were set with a 1.5:1 protein:well ratio
|
Resolution 1.50 Å R-free 0.157 |
| 8SHS human liver mitochondrial Aldehyde dehydrogenase ALDH2 Deposited 2023-04-14 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–517(517 aa)
Chain B
1–517(517 aa)
Chain C
1–517(517 aa)
Chain D
1–517(517 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
28 other PDB entries and 59 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | ALDH2_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–500; UniProt 18–517 Author chain B; PDBConstruct 1–500; UniProt 18–517 Author chain C; PDBConstruct 1–500; UniProt 18–517 Author chain D; PDBConstruct 1–500; UniProt 18–517 Author chain E; PDBConstruct 1–500; UniProt 18–517 Author chain F; PDBConstruct 1–500; UniProt 18–517 Author chain G; PDBConstruct 1–500; UniProt 18–517 Author chain H; PDBConstruct 1–500; UniProt 18–517 |